Caley Castelein

Caley Castelein is a declared insider at 3 companies (board member); the most frequent names are ViewRay, Inc., Talaris Therapeutics, Inc. and Whitehawk Therapeutics, Inc. We count 15 filings; the first trade dates from 14 June 2021 and the latest from 28 October 2025.

The open-market side counts 3 purchases for €3.8M alongside 1 sale for €9,612. Purchases outweigh sales by €3.8M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 8 share grants.

A typical purchase (the median) is worth €854k. On 3 out of 3 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

On 28 October 2025 came the latest disclosure, a transaction in Talaris Therapeutics, Inc. The last purchase on record was published on 27 October 2023, which is 1,087 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.